Auspex Pharmaceuticals, Inc.
CIK 0001454189
Revenue (TTM)
—
FY Feb 2015
Net Income (TTM)
−$42.39M
−5.2% YoY
FY Feb 2015
EPS Diluted (TTM)
—
FY Feb 2015
Gross Margin
—
FY Feb 2015
Operating Margin
—
FY Feb 2015
Net Margin
—
FY Feb 2015
Free Cash Flow (TTM)
—
FY Feb 2015
Cash
$29.79M
FY Feb 2015
Total Debt
$15.76M
FY Feb 2015
Shares Outstanding
31.82M sh
FY Feb 2015
Revenue & Net Income
Revenue Growth (YoY)
No data available for this metric.